Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -4.50%3.46B | 2.79%3.45B | -11.33%3.04B | -3.32%3.34B | -6.16%3.62B | -14.89%3.36B | -9.00%3.42B | 0.68%3.46B | 9.70%3.86B | 13.10%3.95B |
Transactional financial assets | ---- | --48.99K | ---- | --44.87K | ---- | ---- | ---- | ---- | ---- | ---- |
Notes receivable and accounts receivable | 6.84%1.61B | -13.58%1.24B | -12.11%1.73B | 2.71%1.91B | -18.49%1.51B | -22.34%1.43B | -16.81%1.97B | -9.17%1.86B | 16.79%1.85B | 20.91%1.85B |
-Notes receivable | --1.99M | --955.74K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Accounts receivable | 6.71%1.61B | -13.64%1.24B | -12.11%1.73B | 2.71%1.91B | -18.49%1.51B | -22.34%1.43B | -16.81%1.97B | -9.17%1.86B | 16.79%1.85B | 20.91%1.85B |
Other receivables (including interest and dividends) | -46.92%123.05M | -44.03%171.11M | -13.56%162.95M | -32.51%204.93M | 77.28%231.82M | 57.34%305.71M | 7.16%188.52M | -24.05%303.66M | 2.04%130.77M | -11.70%194.3M |
-Dividend receivable | ---- | ---- | --4.12M | ---- | ---- | ---- | ---- | ---- | 68.93%32.44M | -16.09%16.49M |
-Other receivable | -46.92%123.05M | ---- | -15.75%158.83M | ---- | 135.77%231.82M | ---- | 17.56%188.52M | ---- | -9.75%98.33M | ---- |
Advance payment | -7.84%239.95M | 19.41%362.87M | 45.77%302.46M | 93.61%348.87M | -2.31%260.36M | 44.55%303.87M | -25.94%207.49M | -21.05%180.19M | 16.05%266.52M | 45.14%210.23M |
Inventories | -13.65%2.58B | -15.22%2.4B | -20.76%2.59B | 4.63%2.88B | 0.22%2.99B | 24.95%2.83B | 22.78%3.26B | -4.59%2.75B | -4.65%2.99B | -18.48%2.27B |
Receivable financing | 65.34%66.98M | -56.78%2.98M | ---- | -51.01%4.98M | 8,576.56%40.51M | --6.9M | 440.17%20.84M | 255.86%10.16M | -91.63%466.91K | ---- |
Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%31.8M | 0.00%31.8M | 0.00%31.8M |
Other current assets | 162.13%689.49M | 17.80%103.74M | -10.21%132.13M | 31.46%193.85M | 33.11%263.03M | 16.91%88.06M | 15.49%147.15M | 2.47%147.45M | -11.69%197.61M | -10.41%75.32M |
Total current assets | -2.54%8.77B | -6.65%7.78B | -13.68%7.98B | 1.56%8.89B | -4.57%9B | -2.77%8.34B | -1.82%9.25B | -5.87%8.75B | 6.49%9.43B | 3.41%8.57B |
Non Current assets | ||||||||||
Other non-current financial assets | 24.35%23.16M | -11.55%23.25M | -20.92%20.38M | 5.23%19.07M | 6.22%18.63M | 55.00%26.28M | 36.81%25.77M | -7.75%18.13M | -7.52%17.54M | -13.39%16.96M |
Investment real estate | -6.96%16.94M | -6.84%17.25M | -6.73%17.57M | -6.62%17.89M | -6.51%18.21M | -6.40%18.52M | -6.30%18.84M | -1.89%19.16M | -6.11%19.47M | 2.75%19.79M |
Long-term equity investment | 3.23%423.61M | 6.23%403.62M | -0.48%403.65M | 3.04%409.29M | 11.76%410.34M | 0.26%379.97M | 11.84%405.59M | 3.73%397.21M | 2.62%367.17M | 14.83%379M |
Fixed assets | 1.89%3.81B | ---- | 5.90%3.95B | ---- | -0.67%3.74B | ---- | -3.45%3.73B | ---- | -4.96%3.77B | ---- |
Fixed assets liquidation | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
Constru in process | -55.91%375.7M | ---- | -33.76%474.79M | ---- | 41.89%852.16M | ---- | 21.89%716.8M | ---- | 24.60%600.59M | ---- |
Productive biological assets | 11.46%178.37M | -30.53%157.76M | -32.83%157.44M | -27.17%148.1M | -12.84%160.02M | 57.34%227.08M | 71.36%234.41M | 25.19%203.35M | 2.23%183.6M | -53.84%144.32M |
Intangible assets | -0.95%161.17M | 20.88%154.67M | 17.70%154.1M | 18.05%161.59M | -1.03%162.72M | -21.82%127.95M | -22.06%130.93M | -18.70%136.88M | 0.89%164.41M | 1.01%163.66M |
Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --175.35K |
Goodwill | 0.00%109.5M | 0.00%109.5M | 0.00%109.5M | 0.00%109.5M | 0.00%109.5M | -30.73%109.5M | -30.73%109.5M | -30.73%109.5M | -30.73%109.5M | 0.00%158.08M |
Long deferred expense | -5.62%151.23M | -6.34%151.22M | 5.31%160.47M | 6.44%161.9M | 9.99%160.23M | 35.50%161.46M | 20.55%152.38M | 16.83%152.1M | 8.86%145.67M | -11.83%119.16M |
Deferred tax assets | 69.56%89.3M | -4.62%39.84M | 39.71%58.36M | 65.47%70.65M | 24.67%52.66M | -2.09%41.77M | -11.22%41.77M | -10.55%42.7M | -20.81%42.24M | 47.44%42.66M |
Usufruct assets | -0.38%502.65M | 4.57%424.97M | 4.24%453.02M | 16.17%482.55M | 22.09%504.57M | -0.74%406.41M | 0.88%434.58M | -6.63%415.39M | -10.04%413.28M | 130.36%409.44M |
Other non current assets | 106.96%271.48M | -8.31%111.94M | -6.38%115.99M | 9.94%126.27M | 11.07%131.18M | 3.86%122.09M | 5.19%123.88M | -2.79%114.85M | -10.68%118.11M | 4.56%117.55M |
Total non current assets | -3.26%6.12B | -0.99%6.04B | -0.80%6.08B | 2.93%6.17B | 6.28%6.32B | 1.41%6.1B | 1.43%6.13B | -2.38%6B | -2.84%5.95B | 2.44%6.01B |
Total assets | -2.84%14.89B | -4.26%13.82B | -8.55%14.06B | 2.11%15.06B | -0.37%15.32B | -1.05%14.43B | -0.55%15.37B | -4.48%14.75B | 2.67%15.38B | 3.01%14.59B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 18.19%2.94B | 11.72%1.93B | -5.49%2.28B | 35.56%2.64B | 35.32%2.48B | -7.07%1.73B | -8.71%2.41B | -29.90%1.95B | -24.93%1.84B | -10.27%1.86B |
Notes payable and accounts payable | -1.05%2.16B | -5.43%1.75B | -4.23%1.73B | 10.85%1.98B | 41.03%2.18B | 53.07%1.85B | 17.82%1.81B | 21.66%1.78B | 19.35%1.54B | -7.36%1.21B |
-Notes payable | --34.19M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Accounts payable | -2.62%2.12B | -5.43%1.75B | -4.23%1.73B | 10.85%1.98B | 41.03%2.18B | 53.07%1.85B | 18.59%1.81B | 22.49%1.78B | 20.84%1.54B | -6.39%1.21B |
Contract liabilities | -34.72%407.82M | -31.71%447.69M | -36.59%387.3M | 5.02%473.17M | -36.60%624.75M | 27.05%655.6M | 29.25%610.75M | -7.77%450.54M | 6.07%985.46M | -17.41%516.02M |
Advance receipts | --3.91M | 641.53%4.38M | ---- | ---- | ---- | -6.05%590K | ---- | ---- | ---- | --628K |
Salaries payable | -7.59%299.33M | -18.19%221.12M | -14.15%271.84M | -9.60%271.82M | -16.61%323.92M | -10.89%270.28M | -14.20%316.67M | -7.33%300.7M | -4.40%388.46M | -3.59%303.31M |
Taxs payable | -42.00%86.87M | 67.49%131.8M | 44.85%108.08M | -7.97%127.99M | -57.37%149.76M | -78.30%78.69M | -79.32%74.61M | -54.32%139.08M | 43.85%351.34M | 31.91%362.65M |
Other payable (including interest and dividends) | -5.52%1.26B | -1.68%1.22B | -8.44%1.25B | 4.97%1.51B | -5.50%1.33B | -7.75%1.24B | 12.46%1.36B | 18.19%1.44B | 38.76%1.41B | 46.04%1.34B |
-Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | -43.41%637.96K | 196.69%6.73M | -13.50%5.73M | 1,432.20%669.49K |
-Dividend payable | 0.00%71.05M | 7.87%78.77M | -37.65%81.21M | 0.00%71.05M | 0.00%71.05M | -5.69%73.02M | 67.80%130.25M | -59.26%71.05M | -35.32%71.05M | -29.57%77.43M |
-Other payable | -5.83%1.19B | ---- | -5.31%1.17B | ---- | -5.39%1.26B | ---- | 8.73%1.23B | 30.79%1.36B | 48.19%1.33B | 56.23%1.27B |
Non current liabilities due within one year | -66.30%261.29M | -46.46%149.43M | -40.35%164.24M | 108.83%686.98M | 119.17%775.41M | 192.49%279.1M | 148.39%275.34M | 73.52%328.97M | 67.15%353.79M | --95.42M |
Other current liabilities | 105.46%113.61M | -46.13%37.54M | -60.88%28.69M | -28.88%35.91M | -53.75%55.3M | 22.89%69.69M | 86.26%73.33M | -5.19%50.49M | 5.67%119.55M | --56.71M |
Total current liabilities | -3.70%7.63B | -5.02%5.89B | -10.69%6.22B | 20.13%7.78B | 13.27%7.92B | 5.41%6.21B | 2.00%6.97B | -5.04%6.48B | 4.23%7B | 6.48%5.89B |
Current liabilities | ||||||||||
Long term loan | -71.44%57.16M | -76.47%180.79M | -76.47%180.79M | -73.94%200.18M | -73.79%200.18M | 3.97%768.18M | 4.98%768.18M | 28.60%768.18M | 42.70%763.69M | 23.94%738.87M |
Long term account payable | ---- | ---- | ---- | ---- | ---- | ---- | -68.84%18.81M | ---- | -58.34%26.59M | ---- |
Long term salaries pay | 19.88%40.04M | -3.56%45.79M | -10.44%30.71M | -7.27%45.03M | -7.25%33.4M | 3.05%47.48M | -27.36%34.29M | -3.26%48.57M | -3.33%36.01M | -23.36%46.07M |
Estimate liabilities | 42.20%54.34M | -11.18%31.16M | -2.92%27.79M | 24.09%36.17M | -0.08%38.22M | 4.17%35.09M | 5.50%28.62M | -22.80%29.15M | 2.90%38.25M | -52.65%33.68M |
Deferred tax liabilities | 0.03%3.12M | -91.20%4.26M | 1.93%49.68M | -92.86%3.24M | -92.50%3.12M | -26.10%48.42M | -2.78%48.74M | -9.15%45.32M | -15.88%41.61M | 28.49%65.52M |
Long term deferred income | 51.09%7.79M | -2.53%4.71M | -10.02%4.71M | -37.84%5M | -22.93%5.15M | -98.86%4.84M | -98.79%5.24M | -98.20%8.04M | -98.47%6.69M | -8.56%424.91M |
Lease liabilities | 4.40%377.06M | -6.25%353.12M | -6.18%377.29M | 12.60%407.64M | 8.29%361.16M | -5.82%376.67M | -3.82%402.13M | -12.84%362.01M | -16.85%333.5M | 123.48%399.94M |
Total non current liabilities | -15.86%539.52M | -52.30%619.84M | -48.62%670.97M | -45.53%697.26M | -48.55%641.23M | -26.28%1.3B | -26.12%1.31B | -22.82%1.28B | -20.18%1.25B | 17.62%1.76B |
Total liabilities | -4.61%8.17B | -13.21%6.51B | -16.68%6.89B | 9.30%8.48B | 3.92%8.57B | -1.89%7.51B | -3.78%8.27B | -8.52%7.76B | -0.38%8.24B | 8.86%7.65B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%937.73M | 0.00%937.73M | 0.00%937.73M | 0.00%937.73M | 0.00%937.73M | 0.00%937.73M | 0.00%937.73M | 0.00%937.73M | 0.00%937.73M | 0.00%937.73M |
Capital reserve funds | -2.73%1.77B | -3.99%1.74B | -2.41%1.77B | 0.00%1.82B | 0.00%1.82B | 0.01%1.82B | 0.01%1.82B | 0.01%1.82B | 0.01%1.82B | 0.01%1.82B |
Surplus reserve funds | 16.15%262.74M | 0.00%226.21M | 0.00%226.21M | 0.00%226.21M | 0.00%226.21M | 23.27%226.21M | 23.27%226.21M | 23.27%226.21M | 23.27%226.21M | 14.78%183.5M |
Retained profit | 5.46%2.15B | 9.51%2.35B | 2.79%2.22B | -1.97%2.13B | 2.95%2.03B | 11.03%2.14B | 16.40%2.16B | 20.15%2.18B | 22.76%1.98B | 15.62%1.93B |
Other composite income | -235.23%-216.7M | 43.57%-90.73M | 0.90%-115.06M | 38.89%-167.3M | 41.23%-64.64M | 28.88%-160.78M | 42.93%-116.1M | -130.85%-273.78M | 26.04%-109.98M | -99.91%-226.07M |
Shareholders equity without minority interests | -1.09%4.9B | 4.06%5.16B | 0.35%5.04B | 1.30%4.95B | 2.14%4.95B | 6.92%4.96B | 9.47%5.02B | 5.46%4.88B | 10.18%4.85B | 3.84%4.64B |
Minority interests | 0.75%1.82B | 8.94%2.14B | 2.32%2.13B | -22.42%1.64B | -21.14%1.81B | -14.33%1.96B | -8.53%2.08B | -9.53%2.11B | -0.71%2.29B | -13.83%2.29B |
Total shareholder equity | -0.60%6.71B | 5.44%7.3B | 0.93%7.17B | -5.85%6.58B | -5.33%6.75B | -0.11%6.93B | 3.51%7.1B | 0.44%6.99B | 6.44%7.13B | -2.76%6.93B |
Total liabilityies and equity | -2.84%14.89B | -4.26%13.82B | -8.55%14.06B | 2.11%15.06B | -0.37%15.32B | -1.05%14.43B | -0.55%15.37B | -4.48%14.75B | 2.67%15.38B | 3.01%14.59B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.